Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.

ClinicalTrials.gov public records Last synced May 21, 2026, 9:51 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–3 of 3 matching trials from the live ClinicalTrials.gov search.

Local D1 index available.

Filters: Condition: Congenital Nephrogenic Diabetes Insipidus Clear all

Completed Phase 2 Interventional

Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration

NCT05190744

View directory record Official record

Conditions: Autosomal Dominant Polycystic Kidney Disease, Nephrogenic Diabetes Insipidus, Acquired Nephrogenic Diabetes Insipidus, Congenital Nephrogenic Diabetes Insipidus
Interventions: PB; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older

Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Jacksonville, Florida

Source: ClinicalTrials.gov public record

Updated Jan 26, 2026 · Synced May 21, 2026, 9:51 PM EDT

Completed Not applicable Interventional Results available

Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus

NCT00478335

View directory record Official record

Conditions: Nephrogenic Diabetes Insipidus
Interventions: sildenafil, calcitonin, hydrochlorothiazide/amiloride, indomethacin, Placebo for sildenafil, placebo for calcitonin; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 5 Years to 25 Years · Male only

Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: Aurora, Colorado

Source: ClinicalTrials.gov public record

Updated Feb 11, 2018 · Synced May 21, 2026, 9:51 PM EDT

Terminated Phase 1 Interventional

Metformin and Congenital Nephrogenic Diabetes Insipidus

NCT02460354

View directory record Official record

Conditions: Diabetes Insipidus
Interventions: Metformin; Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older · Male only

Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 3
States / cities: Atlanta, Georgia

Source: ClinicalTrials.gov public record

Updated Jul 16, 2018 · Synced May 21, 2026, 9:51 PM EDT